Literature DB >> 8480146

Adult idiopathic polymyositis without elevation of creatine kinase. Case report and review of the literature.

J T Gran1, G Myklebust, S Johansen.   

Abstract

A patient fulfilling diagnostic criteria for definite polymyositis, but with normal levels of creatine kinase (CK) is reported. Review of the literature reveals significant variations regarding the frequencies of normal CK reported among cases with myositis. The discrepancies may be partly explained by inclusion of both probable and possible polymyositis, administration of steroid therapy prior to estimations of CK, and possible differences in CK levels between polymyositis and dermatomyositis. The patient reported did not suffer from neither lung disease nor concomitant malignancy. Thus, the alleged association between low levels of CK and poor prognosis in myositis could not be supported by the present case report.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8480146     DOI: 10.3109/03009749309095123

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

Review 1.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

2.  Serum levels of adipokines in patients with idiopathic inflammatory myopathies: a pilot study.

Authors:  Javier Loaiza-Félix; Mariana Moreno-Ramírez; F Luis Pérez-García; Valentín Jiménez-Rojas; Fausto Sánchez-Muñoz; M Luis Amezcua-Guerra
Journal:  Rheumatol Int       Date:  2017-05-23       Impact factor: 3.580

3.  Dermatomyositis without elevation of creatine kinase presented as bronchiolitis obliterans organizing pneumonia.

Authors:  Y H Lee; S J Choi; J D Ji; J J Shim; K H Kang; H D Cho; H K Kim; G G Song
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

4.  Recurrent Bilateral Focal Myositis.

Authors:  Hiroko Nagafuchi; Hiromasa Nakano; Seido Ooka; Yukiko Takakuwa; Hidehiro Yamada; Mamoru Tadokoro; Sadatomo Shimojo; Shoichi Ozaki
Journal:  Intern Med       Date:  2016-11-15       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.